(1)
Subroto, D. R. T.; Triguna, I. P. B. A Severe Hyponatremia in a Renal Cell Carcinoma Patient Treated With Pembrolizumab: Possible Immune Checkpoint Inhibitor–Induced Secondary Adrenal Insufficiency. InaJBCS 2025, 57, 46-47.